IN2014DN09791A - - Google Patents
Info
- Publication number
- IN2014DN09791A IN2014DN09791A IN9791DEN2014A IN2014DN09791A IN 2014DN09791 A IN2014DN09791 A IN 2014DN09791A IN 9791DEN2014 A IN9791DEN2014 A IN 9791DEN2014A IN 2014DN09791 A IN2014DN09791 A IN 2014DN09791A
- Authority
- IN
- India
- Prior art keywords
- conjugates
- disclosed
- meningococcal
- immunogenic
- against meningococcal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261651382P | 2012-05-24 | 2012-05-24 | |
PCT/US2013/042428 WO2013177397A1 (en) | 2012-05-24 | 2013-05-23 | Multivalent meningococcal conjugates and methods for preparing cojugates |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN09791A true IN2014DN09791A (pt) | 2015-07-31 |
Family
ID=48579502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN9791DEN2014 IN2014DN09791A (pt) | 2012-05-24 | 2014-11-19 |
Country Status (4)
Country | Link |
---|---|
US (2) | US9427476B2 (pt) |
CN (1) | CN104428008B (pt) |
IN (1) | IN2014DN09791A (pt) |
WO (1) | WO2013177397A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2270173T3 (en) | 1999-05-19 | 2016-03-07 | Glaxosmithkline Biolog Sa | Neisserial combination compositions |
GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
CA2716212A1 (en) | 2008-02-21 | 2009-08-27 | Novartis Ag | Meningococcal fhbp polypeptides |
AU2010227219B2 (en) | 2009-03-24 | 2014-02-27 | Glaxosmithkline Biologicals S.A. | Adjuvanting meningococcal factor H binding protein |
CN104428008B (zh) * | 2012-05-24 | 2020-10-09 | 美国政府(由卫生和人类服务部的部长所代表) | 多价脑膜炎球菌缀合物及制备缀合物的方法 |
NZ630133A (en) * | 2012-06-14 | 2016-10-28 | Novartis Ag | Vaccines for serogroup x meningococcus |
CN109890413B (zh) | 2016-09-02 | 2024-04-16 | 赛诺菲巴斯德股份有限公司 | 脑膜炎奈瑟氏菌疫苗 |
CN108144056A (zh) * | 2016-12-02 | 2018-06-12 | 武汉博沃生物科技有限公司 | 多价肺炎球菌多糖结合疫苗及其制备方法 |
CN107961369B (zh) * | 2017-03-22 | 2020-08-11 | 武汉博沃生物科技有限公司 | 多价脑膜炎球菌缀合疫苗及其制备方法 |
GB202016604D0 (en) * | 2020-10-20 | 2020-12-02 | Univ Of Oxford | Compositions and methods for inducing an immune response |
CN117643624A (zh) * | 2024-01-30 | 2024-03-05 | 成都康华生物制品股份有限公司 | 一种双价多糖结合疫苗的制备方法及双价多糖结合疫苗 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
EP0772619B2 (en) | 1994-07-15 | 2010-12-08 | The University of Iowa Research Foundation | Immunomodulatory oligonucleotides |
US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
JP2001513776A (ja) | 1997-02-28 | 2001-09-04 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | LPS関連障害の処置における非メチル化CpGジヌクレオチドを含む核酸の使用 |
US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
AU7690898A (en) | 1997-05-20 | 1998-12-11 | Ottawa Civic Hospital Loeb Research Institute | Vectors and methods for immunization or therapeutic protocols |
JP2002510644A (ja) | 1998-04-03 | 2002-04-09 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | 免疫治療用オリゴヌクレオチドおよびサイトカインを用いる免疫系刺激のための方法および産物 |
AU2001250882A1 (en) | 2000-03-20 | 2001-10-03 | Massachusetts Institute Of Technology | Inorganic particle conjugates |
GB0220197D0 (en) | 2002-08-30 | 2002-10-09 | Univ Utrecht | Refolding method |
EP1651261B1 (en) | 2003-08-06 | 2014-10-08 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Polysaccharide-protein conjugate vaccines |
US8048432B2 (en) | 2003-08-06 | 2011-11-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Polysaccharide-protein conjugate vaccines |
KR101947794B1 (ko) * | 2006-03-17 | 2019-02-13 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 | 복합 다가 면역원성 콘쥬게이트의 제조 방법 |
CA2716212A1 (en) | 2008-02-21 | 2009-08-27 | Novartis Ag | Meningococcal fhbp polypeptides |
JP5806204B2 (ja) | 2009-03-24 | 2015-11-10 | ノバルティス アーゲー | 肺炎球菌血清型14の糖を含む組み合わせ |
JP5668049B2 (ja) | 2009-03-24 | 2015-02-12 | ノバルティス アーゲー | 髄膜炎菌h因子結合タンパク質および肺炎球菌糖結合体の組み合わせ |
WO2011103588A1 (en) | 2010-02-22 | 2011-08-25 | Liquidia Technologies, Inc. | Polysaccharide particle vaccines |
JP2013521327A (ja) | 2010-03-10 | 2013-06-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
CN104428008B (zh) * | 2012-05-24 | 2020-10-09 | 美国政府(由卫生和人类服务部的部长所代表) | 多价脑膜炎球菌缀合物及制备缀合物的方法 |
-
2013
- 2013-05-23 CN CN201380037403.7A patent/CN104428008B/zh active Active
- 2013-05-23 WO PCT/US2013/042428 patent/WO2013177397A1/en active Application Filing
- 2013-05-23 US US14/402,988 patent/US9427476B2/en active Active
-
2014
- 2014-11-19 IN IN9791DEN2014 patent/IN2014DN09791A/en unknown
-
2016
- 2016-08-01 US US15/225,102 patent/US9956278B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104428008B (zh) | 2020-10-09 |
US20160331824A1 (en) | 2016-11-17 |
US20150110829A1 (en) | 2015-04-23 |
US9427476B2 (en) | 2016-08-30 |
WO2013177397A1 (en) | 2013-11-28 |
CN104428008A (zh) | 2015-03-18 |
US9956278B2 (en) | 2018-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014DN09791A (pt) | ||
PH12018501517A1 (en) | Neisseria meningitidis compositions and methods thereof | |
EP4286000A3 (en) | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof | |
BR112012007876A2 (pt) | "membranas de troca de íons" | |
MX2013013111A (es) | Composicion inmunogenica que presenta antigeno multiple, y metodos y usos de la misma. | |
MY167579A (en) | Glycoconjugation processes and compositions | |
WO2015110940A3 (en) | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof | |
MY169837A (en) | Immunogenic compositions of staphylococcus aureus antigens | |
IN2014DN08830A (pt) | ||
GB201101665D0 (en) | Immunogenic compositions | |
MY158438A (en) | Antibodies against human angiopoietin 2 | |
MX2019001761A (es) | Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis. | |
AU2013331781A8 (en) | Immunogenic composition comprising 1 or more Streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising Protein E and/or PilA from Haemophilus influenzae. | |
MX2014014576A (es) | Vacunas para meningococo de serogrupo x. | |
MX2018010920A (es) | Nuevos conjugados de polisacarido-proteina, y procedimiento para obtener los mismos. | |
MX2020002084A (es) | Conjugados de peptido, proceso de conjugacion y usos de los mismos. | |
BR112012007877A2 (pt) | meios e métodos para produção de polissacarídeos capsulares artificiais de neisseria meningitidis | |
WO2012103444A3 (en) | Immunogenic compositions and reagents for preparing | |
WO2015181834A3 (en) | Novel semi-synthetic meningococcal conjugate vaccine | |
EP3448424A4 (en) | NOVEL CONJUGATE FOR THE VACCINATION OF TYPHUS WITH CHEMICAL CONJUGATE OF VI-POLYSACCHARIDE AND FLAGELLIN, METHOD FOR THE PRODUCTION THEREOF AND COMPOSITION WITH THE CONJUGATE | |
MX349930B (es) | Composiciones inmunogenas. |